Literature DB >> 12577253

Neuropathic pain and diabetes.

Dilip Kapur1.   

Abstract

Neuropathic pain is a common phenomenon resulting from injury to the central or peripheral nervous system. The means by which diabetes results in nerve injury is unclear but the effect is to cause injury at all levels of the nervous system from the level of the peripheral nerves to the brain. Nerve injury causes pain through a cascade of mechanisms resulting in altered processing of sensory input into the nervous system. This alteration occurs through chemical and anatomical changes in the nervous system that are similar to some of the processes seen in central sensitisation following acute pain. Following nerve injury, neuropathic pain occurs not only when these mechanisms are activated but also when sensitisation is maintained. Other processes occurring in neuropathic pain appear to be a loss of normal inhibitory controls as seen by a reduction in local GABA-ergic and descending monoaminergic influences. There are also important changes mediated via glial cells that can maintain neuropathic pain. Diabetes affects all areas of the nervous system and the contribution of higher levels of the nervous system is often overlooked. Neurophysiological and MRI evidence strongly suggest that these may contribute to the pain of diabetic neuropathy. Psychological dysfunction in diabetic patients is an important factor in increasing the suffering associated with all aspects of the disease, but treatment and control of pain can greatly improve the quality of life. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12577253     DOI: 10.1002/dmrr.359

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  13 in total

Review 1.  Painful diabetic neuropathy.

Authors:  S Tesfaye; P Kempler
Journal:  Diabetologia       Date:  2005-05       Impact factor: 10.122

2.  Skeletal Muscle Reflex-Induced Sympathetic Dysregulation and Sensitization of Muscle Afferents in Type 1 Diabetic Rats.

Authors:  Rie Ishizawa; Han-Kyul Kim; Norio Hotta; Gary A Iwamoto; Wanpen Vongpatanasin; Jere H Mitchell; Scott A Smith; Masaki Mizuno
Journal:  Hypertension       Date:  2020-02-17       Impact factor: 10.190

3.  Antinociceptive activities of lidocaine and the nav1.8 blocker a803467 in diabetic rats.

Authors:  Tufan Mert; Yasemin Gunes
Journal:  J Am Assoc Lab Anim Sci       Date:  2012       Impact factor: 1.232

4.  Macrophage depletion delays progression of neuropathic pain in diabetic animals.

Authors:  Tufan Mert; Ismail Gunay; Isil Ocal; A Irfan Guzel; Tamer C Inal; Leman Sencar; Sait Polat
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-13       Impact factor: 3.000

5.  Concurrent activation of the somatosensory forebrain and deactivation of periaqueductal gray associated with diabetes-induced neuropathic pain.

Authors:  Pamela E Paulson; John W Wiley; Thomas J Morrow
Journal:  Exp Neurol       Date:  2007-09-12       Impact factor: 5.330

6.  The beneficial effects of C-Peptide on diabetic polyneuropathy.

Authors:  Hideki Kamiya; Weixian Zhang; Anders A F Sima
Journal:  Rev Diabet Stud       Date:  2009-11-10

7.  Transplantation of bone marrow-derived mononuclear cells improves mechanical hyperalgesia, cold allodynia and nerve function in diabetic neuropathy.

Authors:  Keiko Naruse; Jun Sato; Megumi Funakubo; Masaki Hata; Nobuhisa Nakamura; Yasuko Kobayashi; Hideki Kamiya; Taiga Shibata; Masaki Kondo; Tatsuhito Himeno; Tatsuaki Matsubara; Yutaka Oiso; Jiro Nakamura
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

8.  Surgical decompression of painful diabetic peripheral neuropathy: the role of pain distribution.

Authors:  Chenlong Liao; Wenchuan Zhang; Min Yang; Qiufeng Ma; Guowei Li; Wenxiang Zhong
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

9.  Selective T-type calcium channel blockade alleviates hyperalgesia in ob/ob mice.

Authors:  Janelle R Latham; Sriyani Pathirathna; Miljen M Jagodic; Won Joo Choe; Michaela E Levin; Michael T Nelson; Woo Yong Lee; Kathiresan Krishnan; Douglas F Covey; Slobodan M Todorovic; Vesna Jevtovic-Todorovic
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

10.  Multifocal Visual Evoked Potentials (mfVEP) in Diabetic Patients with and without Polyneuropathy.

Authors:  Monica Lövestam-Adrian; Lotta Gränse; Gert Andersson; Sten Andreasson
Journal:  Open Ophthalmol J       Date:  2012-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.